يعرض 1 - 10 نتائج من 251 نتيجة بحث عن '"Kipps, T. J."', وقت الاستعلام: 0.91s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study

    المؤلفون: Woyach J. A., Barr P. M., Kipps T. J., Barrientos J. C., Ahn I. E., Ghia P., Girardi V., Hsu E., Jermain M., Burger J. A.

    المساهمون: Woyach, J. A., Barr, P. M., Kipps, T. J., Barrientos, J. C., Ahn, I. E., Ghia, P., Girardi, V., Hsu, E., Jermain, M., Burger, J. A.

    مصطلحات موضوعية: chronic lymphocytic leukemia, ibrutinib, long-term outcomes

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36672456; info:eu-repo/semantics/altIdentifier/wos/WOS:000914618200001; volume:15; issue:2; numberofpages:16; journal:CANCERS; https://hdl.handle.net/20.500.11768/143810Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85146791771; https://www.mdpi.com/2072-6694/15/2/507Test

    الإتاحة: https://doi.org/20.500.11768/143810Test
    https://doi.org/10.3390/cancers15020507Test
    https://hdl.handle.net/20.500.11768/143810Test
    https://www.mdpi.com/2072-6694/15/2/507Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    P669: FIXED-DURATION (FD) IBRUTINIB + VENETOCLAX FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): 3-YEAR FOLLOW-UP FROM THE PHASE 2 CAPTIVATE STUDY FD COHORT

    المؤلفون: Moreno, C., Wierda, W. G., Barr, P. M., Siddiqi, T., Allan, J. N., Kipps, T. J., Trentin, L., Jacobs, R., Jackson, S., Tedeschi, A., Opat, S., Bannerji, R., Kuss, B. J., Croner, L. J., Szafer-Glusman, E., Zhou, C., Szoke, A., Dean, J. P., Ghia, P., Tam, C. S.

    المصدر: HemaSphere ; volume 6, page 567-568 ; ISSN 2572-9241

    الإتاحة: https://doi.org/10.1097/01.hs9.0000845560.07338.2dTest

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study

    المؤلفون: Burger J. A., Barr P. M., Robak T., Owen C., Ghia P., Tedeschi A., Bairey O., Hillmen P., Coutre S. E., Devereux S., Grosicki S., McCarthy H., Simpson D., Offner F., Moreno C., Dai S., Lal I., Dean J. P., Kipps T. J.

    المساهمون: Burger, J. A., Barr, P. M., Robak, T., Owen, C., Ghia, P., Tedeschi, A., Bairey, O., Hillmen, P., Coutre, S. E., Devereux, S., Grosicki, S., Mccarthy, H., Simpson, D., Offner, F., Moreno, C., Dai, S., Lal, I., Dean, J. P., Kipps, T. J.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31628428; info:eu-repo/semantics/altIdentifier/wos/WOS:000519468700010; volume:34; issue:3; firstpage:787; lastpage:798; numberofpages:12; journal:LEUKEMIA; https://hdl.handle.net/20.500.11768/143811Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85074797641; https://www.nature.com/articles/s41375-019-0602-xTest

    الإتاحة: https://doi.org/20.500.11768/143811Test
    https://doi.org/10.1038/s41375-019-0602-xTest
    https://hdl.handle.net/20.500.11768/143811Test
    https://www.nature.com/articles/s41375-019-0602-xTest

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Ibrutinib plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia : Primary Analysis Results from the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE Study

    المؤلفون: Wierda, W. G., Allan, J. N., Siddiqi, T., Kipps, T. J., Opat, S., Tedeschi, Alessandra, Badoux, X. C., Kuss, B. J., Jackson, S., Moreno, Carol, Jacobs, R. M. D., Pagel, J. M., Flinn, I., Pak, Y., Zhou, Cathy, Szafer-Glusman, E., Ninomoto, J., Dean, James P, James, D. F., Ghia, Paolo, Tam, C. S., Universitat Autònoma de Barcelona

    مصطلحات موضوعية: Adenine, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Bridged Bicyclo Compounds, Heterocyclic, Cohort Studies, Female, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Male, Middle Aged, Neoplasm, Residual, Piperidines, Sulfonamides, Survival Analysis

    وصف الملف: application/pdf

    العلاقة: Journal of Clinical Oncology; Vol. 39 Núm. 34 (january 2021), p. 3853-3865; https://ddd.uab.cat/record/264650Test; urn:10.1200/JCO.21.00807; urn:oai:ddd.uab.cat:264650; urn:scopus_id:85121427097; urn:articleid:15277755v39n34p3853; urn:pmid:34618601; urn:pmc-uid:8713593; urn:pmcid:PMC8713593; urn:oai:pubmedcentral.nih.gov:8713593

    الإتاحة: https://ddd.uab.cat/record/264650Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    CAPTIVATE PRIMARY ANALYSIS OF FIRSTâ€LINE TREATMENT WITH FIXEDâ€DURATION IBRUTINIB PLUS VENETOCLAX FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL)

    المؤلفون: Tam, C. S. L, Allan, J. N, Siddiqi, T, Kipps, T. J, Jacobs, R, Opat, S, Barr, P. M, Tedeschi, A, Trentin, L, Bannerji, R, Jackson, S, Kuss, B, Moreno, C, Szaferâ€Glusman, E, Russell, K, Zhou, C, Ninomoto, J, Dean, J. P, Ghia, P, Wierda, W. G

    مصطلحات موضوعية: Cancer Research, Oncology, Hematology, General Medicine

    العلاقة: url:https://www.openaccessrepository.it/communities/itmirrorTest; https://www.openaccessrepository.it/record/183714Test

    الإتاحة: https://doi.org/10.1002/hon.32_2879Test
    https://www.openaccessrepository.it/record/183714Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    FIRST‐LINE TREATMENT WITH IBRUTINIB FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): 7‐YEAR RESULTS FROM RESONATE‐2

    المؤلفون: Coutre, S. E., Barr, P. M., Owen, C., Robak, T., Tedeschi, A., Bairey, O., Burger, J. A., Hillmen, P., Devereux, S., Grosicki, S., McCarthy, H., Li, J., Simpson, D., Offner, F., Moreno, C., Dai, S., Szoke, A., Dean, J. P., Kipps, T. J., Ghia, P.

    المصدر: Hematological Oncology ; volume 39, issue S2 ; ISSN 0278-0232 1099-1069

    الإتاحة: https://doi.org/10.1002/hon.48_2880Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia

    المؤلفون: Allan J. N., Flinn I. W., Siddiqi T., Ghia P., Tam C. S., Kipps T. J., Barr P. M., Elinder Camburn A., Tedeschi A., Badoux X. C., Jacobs R., Kuss B. J., Trentin L., Zhou C., Szoke A., Abbazio C., Wierda W. G.

    المساهمون: Allan, J. N., Flinn, I. W., Siddiqi, T., Ghia, P., Tam, C. S., Kipps, T. J., Barr, P. M., Elinder Camburn, A., Tedeschi, A., Badoux, X. C., Jacobs, R., Kuss, B. J., Trentin, L., Zhou, C., Szoke, A., Abbazio, C., Wierda, W. G.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37282671; info:eu-repo/semantics/altIdentifier/wos/WOS:001042090500001; volume:29; issue:14; firstpage:2593; lastpage:2601; numberofpages:9; journal:CLINICAL CANCER RESEARCH; https://hdl.handle.net/11577/3491440Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85164845430

    الإتاحة: https://doi.org/10.1158/1078-0432.CCR-22-2779Test
    https://hdl.handle.net/11577/3491440Test

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study

    المؤلفون: Ramassone A., D'Argenio A., Veronese A., Basti A., Soliman S. H. A., Volinia S., Bassi C., Pagotto S., Ferracin M., Lupini L., Saccenti E., Balatti V., Pepe F., Rassenti L. Z., Innocenti I., Autore F., Marzetti L., Mariani-Costantini R., Kipps T. J., Negrini M., Laurenti L., Visone R.

    المساهمون: Ramassone, A., D'Argenio, A., Veronese, A., Basti, A., Soliman, S. H. A., Volinia, S., Bassi, C., Pagotto, S., Ferracin, M., Lupini, L., Saccenti, E., Balatti, V., Pepe, F., Rassenti, L. Z., Innocenti, I., Autore, F., Marzetti, L., Mariani-Costantini, R., Kipps, T. J., Negrini, M., Laurenti, L., Visone, R.

    مصطلحات موضوعية: Chronic lymphocytic leukemia, Clonal evolution, Copy number variation, Nucleotide variation

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31744508; info:eu-repo/semantics/altIdentifier/wos/WOS:000510914500001; volume:12; issue:1; firstpage:114-1; lastpage:114-5; numberofpages:5; journal:JOURNAL OF HEMATOLOGY & ONCOLOGY; http://hdl.handle.net/11392/2412460Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85075309544; https://jhoonline.biomedcentral.com/articles/10.1186/s13045-019-0802-xTest

    الإتاحة: https://doi.org/10.1186/s13045-019-0802-xTest
    http://hdl.handle.net/11392/2412460Test

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Hnrnpl restrains MIR-155 targeting of BUB1 to stabilize aberrant karyotypes of transformed cells in chronic lymphocytic leukemia

    المؤلفون: Pagotto S., Veronese A., Soranno A., Balatti V., Ramassone A., Guanciali-Franchi P. E., Palka G., Innocenti I., Autore F., Rassenti L. Z., Kipps T. J., Mariani-Costantini R., Laurenti L., Croce C. M., Visone R.

    المساهمون: Pagotto, S., Veronese, A., Soranno, A., Balatti, V., Ramassone, A., Guanciali-Franchi, P. E., Palka, G., Innocenti, I., Autore, F., Rassenti, L. Z., Kipps, T. J., Mariani-Costantini, R., Laurenti, L., Croce, C. M., Visone, R.

    مصطلحات موضوعية: BUB1, CIN, CLL and microRNA, HNRNPL, MiR-155

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31018621; info:eu-repo/semantics/altIdentifier/wos/WOS:000467773400143; volume:11; issue:4; numberofpages:16; journal:CANCERS; http://hdl.handle.net/11564/706491Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85065441433; https://www.mdpi.com/2072-6694/11/4/575/pdfTest

    الإتاحة: https://doi.org/10.3390/cancers11040575Test
    http://hdl.handle.net/11564/706491Test
    https://www.mdpi.com/2072-6694/11/4/575/pdfTest

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    MURANO: Final 7 year follow up and retreatment analysis in venetoclax‐rituximab (VenR)‐treated patients with relapsed/refractory chronic lymphocytic leukemia ( R/ R CLL)

    المؤلفون: Kater, A. P., Harrup, R., Kipps, T. J., Eichhorst, B., Owen, C. J., Assouline, S., Lamanna, N., Robak, T., Serna, J. d. l., Jaeger, U., Cartron, G., Montillo, M., Mellink, C., Chyla, B., Thadani‐Mulero, M., Lefebure, M., Jiang, Y., Millen, R., Boyer, M., Seymour, J. F.

    المصدر: Hematological Oncology ; volume 41, issue S2, page 239-242 ; ISSN 0278-0232 1099-1069

    الإتاحة: https://doi.org/10.1002/hon.3163_156Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث